Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $350.00 | 1 | 50.7% |
| Food and Beverage | $340.32 | 8 | 49.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| W. L. Gore & Associates, Inc. | $350.00 | 1 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $111.34 | 1 | $0 (2017) |
| Genentech USA, Inc. | $95.83 | 1 | $0 (2017) |
| Medtronic Vascular, Inc. | $31.11 | 1 | $0 (2018) |
| ABBVIE INC. | $28.71 | 1 | $0 (2023) |
| Amgen Inc. | $27.50 | 1 | $0 (2017) |
| Medtronic, Inc. | $18.51 | 1 | $0 (2022) |
| GE HEALTHCARE | $14.46 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $12.86 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $41.57 | 2 | ABBVIE INC. ($28.71) |
| 2022 | $368.51 | 2 | W. L. Gore & Associates, Inc. ($350.00) |
| 2021 | $14.46 | 1 | GE HEALTHCARE ($14.46) |
| 2018 | $31.11 | 1 | Medtronic Vascular, Inc. ($31.11) |
| 2017 | $234.67 | 3 | Avanir Pharmaceuticals, Inc. ($111.34) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.86 | General |
| Category: Cardiovascular | ||||||
| 05/02/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/11/2022 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Pacemakers | ||||||
| 10/21/2022 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Devices | ||||||
| 04/23/2021 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| 10/17/2018 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/30/2017 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $95.83 | General |
| Category: Immunology | ||||||
| 11/12/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Cardiology | ||||||
| 01/31/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $111.34 | General |
| Category: pseudobulbar affect PBA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 165 | 229 | $74,090 | $21,300 |
| 2022 | 5 | 218 | 279 | $93,708 | $27,805 |
| 2021 | 5 | 221 | 281 | $91,385 | $28,119 |
| 2020 | 5 | 224 | 276 | $89,132 | $26,867 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 73 | $37,522 | $8,216 | 21.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 89 | $23,407 | $8,017 | 34.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 52 | $9,516 | $3,150 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $3,645 | $1,916 | 52.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 89 | $45,746 | $12,957 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 62 | $16,306 | $4,904 | 30.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 89 | $16,287 | $4,882 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 25 | $5,723 | $3,119 | 54.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 14 | $9,646 | $1,943 | 20.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 87 | 88 | $45,232 | $13,196 | 29.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 62 | 100 | $18,300 | $5,659 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 63 | $16,569 | $5,024 | 30.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 19 | $3,705 | $2,404 | 64.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 11 | $7,579 | $1,836 | 24.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 89 | 89 | $45,746 | $13,320 | 29.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 74 | 117 | $21,411 | $6,701 | 31.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 16 | 17 | $11,713 | $2,759 | 23.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 31 | $4,476 | $2,252 | 50.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 22 | $5,786 | $1,835 | 31.7% |
About Dr. Amit Kandel, MBBS
Dr. Amit Kandel, MBBS is a Vascular Neurology healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1174899504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Kandel, MBBS has received a total of $690.32 in payments from pharmaceutical and medical device companies, with $41.57 received in 2023. These payments were reported across 9 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($350.00).
As a Medicare-enrolled provider, Kandel has provided services to 828 Medicare beneficiaries, totaling 1,065 services with total Medicare billing of $104,091. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Vascular Neurology
- Location Buffalo, NY
- Active Since 03/29/2012
- Last Updated 03/29/2012
- Taxonomy Code 2084V0102X
- Entity Type Individual
- NPI Number 1174899504
Products in Payments
- Product in Development (Device) $350.00
- NUEDEXTA (Drug) $111.34
- OCREVUS (Biological) $95.83
- Reveal LINQ (Device) $31.11
- BOTOX (Biological) $28.71
- Repatha (Biological) $27.50
- AZURE XT DR MRI SURESCAN (Device) $18.51
- CAMZYOS (Drug) $12.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.